Literature DB >> 21332897

The aetiology of bacterial vaginosis.

Y Turovskiy1, K Sutyak Noll, M L Chikindas.   

Abstract

Bacterial vaginosis (BV) is the most common vaginal infection among women of childbearing age. This condition is notorious for causing severe complications related to the reproductive health of women. Five decades of intense research established many risk factors for acquisition of BV; however, because of the complexity of BV and lack of a reliable animal model for this condition, its exact aetiology remains elusive. In this manuscript, we use a historical perspective to critically review the development of major theories on the aetiology of BV, ultimately implicating BV-related pathogens, healthy vaginal microbiota, bacteriophages and the immune response of the host. None of these theories on their own can reliably explain the epidemiological data. Instead, BV is caused by a complex interaction of multiple factors, which include the numerous components of the vaginal microbial ecosystem and their human host. Many of these factors are yet to be characterized because a clear understanding of their relative contribution to the aetiology of BV is pivotal to the formulation of an effective treatment for and prophylaxis of this condition.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Year:  2011        PMID: 21332897      PMCID: PMC3072448          DOI: 10.1111/j.1365-2672.2011.04977.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  203 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

2.  Haemophilus vaginalis: morphology, cultural characters and viability.

Authors:  P N EDMUNDS
Journal:  J Pathol Bacteriol       Date:  1960-04

3.  Antibiosis between bacteria isolated from the vagina of women with and without signs of bacterial vaginosis.

Authors:  E Nagy; M Petterson; P A Mårdh
Journal:  APMIS       Date:  1991-08       Impact factor: 3.205

4.  Amoxycillin, augmentin and metronidazole in bacterial vaginosis associated with Gardnerella vaginalis.

Authors:  J Symonds; A K Biswas
Journal:  Genitourin Med       Date:  1986-04

5.  Factors influencing the composition of the intestinal microbiota in early infancy.

Authors:  John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

6.  Genomic DNA fingerprint analysis of biotype 1 Gardnerella vaginalis from patients with and without bacterial vaginosis.

Authors:  S R Wu; S L Hillier; K Nath
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro.

Authors:  N W McLean; J A McGroarty
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

8.  Bacterial vaginosis and preterm birth: a prospective community-based cohort study.

Authors:  Pippa Oakeshott; Sally Kerry; Sima Hay; Philip Hay
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

Review 9.  The bacteriology of Gardnerella vaginalis.

Authors:  D Taylor-Robinson
Journal:  Scand J Urol Nephrol Suppl       Date:  1984

10.  Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.

Authors:  J Sobel; J F Peipert; J A McGregor; C Livengood; M Martin; J Robbins; C P Wajszczuk
Journal:  Infect Dis Obstet Gynecol       Date:  2001
View more
  77 in total

1.  Mode of action and safety of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050.

Authors:  S Riazi; S E Dover; M L Chikindas
Journal:  J Appl Microbiol       Date:  2012-07-24       Impact factor: 3.772

2.  Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.

Authors:  Vyacheslav Abramov; Valentin Khlebnikov; Igor Kosarev; Guldana Bairamova; Raisa Vasilenko; Natalia Suzina; Andrey Machulin; Vadim Sakulin; Natalia Kulikova; Nadezhda Vasilenko; Andrey Karlyshev; Vladimir Uversky; Michael L Chikindas; Vyacheslav Melnikov
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

3.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 4.  Control of Biofilm Formation: Antibiotics and Beyond.

Authors:  Ammar Algburi; Nicole Comito; Dimitri Kashtanov; Leon M T Dicks; Michael L Chikindas
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

Review 5.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

Review 6.  The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.

Authors:  David Briskey; Patrick Tucker; David W Johnson; Jeff S Coombes
Journal:  Clin Exp Nephrol       Date:  2016-03-10       Impact factor: 2.801

7.  Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis.

Authors:  B Vitali; F Cruciani; G Picone; C Parolin; G Donders; L Laghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-18       Impact factor: 3.267

8.  Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure.

Authors:  B Wang; B B Xiao; C G Shang; K Wang; R S Na; X X Nu; Q Liao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-10       Impact factor: 3.267

Review 9.  New Systems for Studying Intercellular Interactions in Bacterial Vaginosis.

Authors:  Melissa M Herbst-Kralovetz; Richard B Pyles; Adam J Ratner; Laura K Sycuro; Caroline Mitchell
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

10.  Bacteriophages of the Urinary Microbiome.

Authors:  Taylor Miller-Ensminger; Andrea Garretto; Jonathon Brenner; Krystal Thomas-White; Adriano Zambom; Alan J Wolfe; Catherine Putonti
Journal:  J Bacteriol       Date:  2018-03-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.